Graham G. Walmsley, a director at Akero Therapeutics, Inc. (NASDAQ:AKRO), recently acquired a significant amount of the company's common stock. According to a recent SEC filing, Walmsley purchased 200 ...

RBC Capital analyst Owen Birrell maintained a Hold rating on Atlas Arteria (MAQAF – Research Report) on February 6 and set a price target of ...

The unemployment rate, which is derived from a separate survey, declined to 4% from 4.1% the prior month. Economists expected ...

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of ...

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and ...